POTD: Postpartum Hemorrhage

Postpartum hemorrhage (PPH) is classically defined as > 500 cc of blood loss after standard vaginal delivery or >1000 cc after a C-section. However, most recently ACOG redefined PPH as >1000 cc of blood loss OR signs and symptoms of hypovolemia in the setting of bleeding within the first 24 hours. It is an incredibly common event, occurring in almost 1 in 5 postpartum mothers and is the most frequent cause of maternal morbidity in the developed world. 

The 4 T's of Postpartum Hemorrhage

Tone: uterine atony accounts for 70-80% of PPH. Blood flow can reach up to 500-900 ml/min during delivery. Key presentation is the "soft, boggy uterus." The predisposing risk factors are

  • impaired contraction from local inflammation or acidosis of uterine tissue (chorioamnionitis)

  • down regulation of oxytocin receptions (prolonged labor)

  • diminished actin-myosin interaction from enlarged uterus (macrosomia, multiple gestations)

Actions:

  • Bimanual massage: Manually massage the uterus, with one hand internally inside the vagina and pressing against the uterus from below, while applying external pressure with the other hand above the fundus of the uterus. Avoid downward massage by the internal hand as it can cause injury to the blood vessels and potentially cause uterine inversion

  • Uterotonics: there are several available medications that can increase uterine tone, of which the most important the most crucial is oxytocin. Oxytocin is endogenously excreted and induces uterine contraction. It can be given 40 mg IV in a 1 L normal saline bolus and then continued at 200 ml/hr until uterus is firm. Alternatively, it can be given as 10 mg IM x 2. Oxytocin is first-line and should be given in all patients with uterine atony. Other medications can be added as needed, see below:

    • Misoprotsol (Cytotec): a prostaglandin adjunct that stimulates uterine contraction. It can be given as 1000 mcg (usually 5 tablets) rectally or sublingually and has no contraindications in an emergent setting

    • methylergonovine (Methergine): induces smooth muscle contraction. for PPH should be given as 0.2 mg IM every 2-4 hours until max of 5 doses. This should NOT be given IV as it induces severe hypertension and can precipitate CVA and is contraindicated in patients with hypertension

    • Carboprost: a synthetic prostaglandin that induces myometrial contraction and vasoconstriction through smooth muscle contraction. It's given 250 mcg IM or injected into the myometrium, and can be in 15-90 minute intervals for a max dose of 2 mg. Similarly, this should NOT be given IV as it can induce hypertension and severe bronchospasm, and is contraindicated in patients with asthma or HTN

  • Our resuscitation bay has a PPH pharmacy kit! It hands out in the fridge in room 52 and comes with a handy slip with all the dosages, route, frequency and contraindications! Go check it out!

Trauma: Genital tract trauma is the second most common cause of PPH. up to 80% of traumas are minor and occur in the vagina or perineum. However consider harder to reach areas such as cervical Any ongoing bleeding that does not stop with tamponade should be repaired via suturing. Other options include tamponade with a bark balloon, visualized below. Often we don't have these in the emergency room, so consider using a Blakemore tube (fold the distal tip back, inflate the esophageal balloon).

External aortic compression can also be used as an emergency maneuver, where you apply direct firm pressure with a closed fist over the aorta just above the umbilicus. This is obviously a temporizing maneuver and should be used as a bridge to a more permanent solution or during transport to OR, but it remains fairly effective.

Tissue: refers to retained products of conception. any retained products prevents induction of uterine contraction that occurs after disruption of the placenta. Examine the placenta to see if it's intact. If possible, attempt to retrieve products that are visible and within reach via manual or curettage. If it cannot be reached, they required OR.

Thrombin: both inherited and acquired coagulopathies should be considered. There are obviously many different ways to treat coagulopathies that are tailored to specific clinical pictures, of which I will briefly cover and not go through the mechanisms. Consider DIC and hypofibrinogenemia in placental abruptions and amniotic fluid embolism. 

  • If giving MTF, you should also give FFP and platelets in a 1:1:1 ratio

  • For von Willebrand, give DDAVP

  • for DIC, given cryoprecipitate

  • for hemophilia, give factor replacement therapy

A word on TXA: previous recommendations suggest IV TXA. However, the WOMAN trial in 2017 showed no benefit. That being said, there is much debate on the metrics of how this trial was performed, that the exclusion criteria excluded the sickest patients, there are other studies showing benefits of TXA etc. etc. Long story short, evidence is mixed, and since TXA has little adverse events, giving 1 gram IV isn't going to hurt anyone.



POTD: ECMO

Hello everyone! Let's talk about ECMO. I was first introduced to ECMO in the era of pre-vaccine COVID, where it was often hailed as the Hail Marry of solutions for severe COVID cases in younger patients. But ECMO can be used for so much more, including a recently discussed topic - hypothermia.

What is ECMO?

ECMO, or extracorporeal membrane oxygenation, is a prolonged cardiopulmonary support technique that allows oxygenation of the blood bypassing the heart and lungs. It differs from cardiopulmonary bypass in that it requires less anticoagulation and allows for longer duration of treatment. 

Who qualifies for ECMO?

Criteria for ECMO include acute severe cardiac or pulmonary failure that is potentially reversible and has failed conventional treatment and carries a high risk of death. Conditions include:

  • ARDS and severe respiratory failure (severe hypercapnia pH < 7.20, or P/F ratio < 70)

  • poor gas exchange/obstruction (massive PE)

  • acute pulmonary injury: smoke inhalation, contusion, drowning

  • nonischemic cariogenic shock, cardiac/pulmonary trauma, massive PE

  • bridge to lung or cardiac transplant or LVAD

Who does not qualify for ECMO?

Absolute contraindications include:

  • unwitnessed cardiac arrest

  • non-reversible, progressive lung or cardiac disease that is not a transplant candidate

  • pulmonary hypertension

  • advanced cancer

  • >120 kg

Relative contraindications include:

  • older than 75 years

  • CPR > 60 minutes

  • CNS injury

  • multi organ failure or trauma

What types of ECMO exist?

VV or veno-venous: the most common access, typically central vein IVC access (femoral, IJ), passes through oxygenator, and deposits in a large vein near RA (IJ, subclavian)

  • provides respiratory support but not circulatory support

  • pathologies: COPD, ARDS, PNA, smoke inhalation injury, status asthmatics, airway obstruction, drowning

VA or veno-arterial: can be peripheral or central, access is central vein, passes through oxygenator, and deposits in arterial access around pulmonary artery

  • provides both respiratory and cardiac support

  • pathologies: non-ischemic cardiogenic shock, heart/lung transplant, LVAD failure, PE, sepsis

Complications:

  • clot formation

  • bleeding

  • vessel trauma, LV distension

  • North-south syndrome - hypoxia and cyanosis in cephalic and lower extremities outside of range of circuit access

https://wikem.org/wiki/Extracorporeal_membrane_oxygenation

https://www.emra.org/emresident/article/ecmo-in-the-ed/


POTD: Le Fort Fractures

Hello everyone!

For trauma Tuesday, let's discuss Le Fort fractures.

Le Fort fractures are complex facial fractures involving the maxilla, zygoma, and orbital rims. They were discovered by Dr. Rene Le Fort who discovered these "lines of weakness" in skulls of patients with blunt facial traumas. These fractures by nature include the pterygoid structures of the sphenoid bone, which provide stability and support for the mid face. Most commonly seen in MVC, the velocity determines the severity of the fractures, of which there are three categories:

Le Fort I: "floating palate"

- a transverse fracture of the maxillae above the teeth, leaving the body of the maxilla separated from the pterygoid plate and nasal septum. This leads to a "floating palate", where the maxilla and hard palate may be mobile.

- associated with malocclusion and dental fractures

- generally considered a stable fracture

Le Fort II: "floating maxilla"

- fracture that extends superiorly to include the nasal bridge, maxilla, and orbital rim and floors. fractures are typically bilateral and appear triangular in shape

- The maxilla and nose are mobile, the eyes/orbits are not

- can be stable or unstable

Le Fort III: "floating face"

- the rarest and most severe, this fracture involves the bridge of the nose, medial and lateral orbital wall, zygomatic arch, and maxilla. 

- the entire face is mobile, can present as a "dish face" deformity (essentially the face is caved in)

- this is an unstable fracture

Presentation and Evaluation:

Le Fort fractures can present with many features, including facial deformity and emphysema, CSF rhinorrhea, conjunctival hemorrhage, raccoon eyes, hemotympanum and auricular hematoma, and anosmia

Questions to ask:

Can you smell? Can you bite? 

How is your vision?

Is there numbness or tingling in you face?

Exam:

- palpate for signs of crepitus, areas of tenderness, or instability

- visual acuity test - very important considering high risk of ophthalmologic damage

- check mobility by stabilizing the forehead and grabbing the upper teeth/hard palate, and attempt to move the hard palate

-evaluate to c-spine injuries - approximately 1.4% have concomitant c-spine injuries or dislocations

Management:

- Stabilize ABCs. If airway is at risk - understand that it will be a difficult airway, and consider awake intubation. These patients are particularly difficult as oral injury may prevent appropriate jaw displacement for oral intubation. Nasal intubations are contraindicated due to nasal injuries. These are patients where if a definitive airway is needed, cricothyroidotomy should be considered.

- significant nasal bleeding can occur and may present an airway risk. Consider anterior packing and elevation of head of bed to 40-60 degrees. Posterior packing should be avoided due to risk of skull base injuries.

- IV antibiotics should be given in sinus fractures or CSF leaks, which will be the majority of these fractures

- CT with dedicated facial view should be obtained. 

Disposition:

- All Le Fort fractures should be seen by OMFS

- consider Ophtho or NSG consult if there is concern for eye or brain damage/CSF leak

- some stable Le Fort I and II are stable for discharge with follow up, however most will require ICU (for airway management) or direct OR 

http://www.emdocs.net/em3am-le-fort-fractures/

https://www.ncbi.nlm.nih.gov/books/NBK526060/

https://coreem.net/core/le-fort-fractures/